Analystreport

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) had its price target raised by analysts at Nomura to $165.00. They now have a "buy" rating on the stock.

Alexion Pharmaceuticals, Inc  (ALXN) 
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.alexion.com/investor-relations